Foundation Medicine, UnitedHealth Group sales and marketing update

UnitedHealthcare will cover Foundation's FoundationOne genomic profiling assay for patients with metastatic stage IV non-small cell lung cancer (NSCLC). FoundationOne is a laboratory-developed test (...